ANP-15056-96688
2 vaccinations
0 coded responses
14 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 441 / OH
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-16
Dose 1 — Pfizer-BioNTech
-
2021-03-09
Dose 2 — Pfizer-BioNTech
-
2021-03-10
Registered in v-safe
-
2021-03-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to workAdult check-in
- 2021-03-10
-
2021-03-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-04-21
- 2021-06-08
- 2021-09-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-16 | Pfizer-BioNTech | |
| 2 | 2021-03-09 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.